Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.8 |
mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |